Literature DB >> 15202683

Corticosteroids, depression and the role of serotonin.

E Pretorius1.   

Abstract

Patients frequently use medications simultaneously for different complaints, without being aware of the interactions these products may have. An example of this is the simultaneous use of corticosteroids and medications for depression, defiant or aggressive behaviour. Research has also indicated that corticosteroids lower serotonin levels. However, lowered serotonin levels may result in depression, aggression and other psychological conditions. These secondary complaints, caused by the corticosteroids and other products that lower serotonin levels, may then be treated with selective serotonin reuptake inhibitors (SSRIs) or psycho-stimulants (that are known to indirectly increase serotonin levels). The current research takes a look at lowered serotonin levels when using corticosteroids, as well as the interactions with SSRIs and psycho-stimulants. Furthermore, evidence is presented to prove the hypothesis that some individuals with asthma (e.g. children using systemic corticosteroids that lower serotonin levels) might present with symptoms of depression, attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder and even conduct disorder; and that treating these secondary complaints with SSRIs and psycho-stimulants will result in the upregulating of serotonin levels, and that, in turn, will trigger asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15202683     DOI: 10.1515/revneuro.2004.15.2.109

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  3 in total

1.  Prescription Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Depression among Adults with Inflammatory Chronic Conditions in the United States.

Authors:  Nazneen Fatima Shaikh; Usha Sambamoorthi
Journal:  Psychiatr Q       Date:  2020-03

2.  Serotonin modulates the cytokine network in the lung: involvement of prostaglandin E2.

Authors:  G Ménard; V Turmel; E Y Bissonnette
Journal:  Clin Exp Immunol       Date:  2007-09-05       Impact factor: 4.330

3.  Psycho-Behavioural Changes in Dogs Treated with Corticosteroids: A Clinical Behaviour Perspective.

Authors:  Lorella Notari; Roxane Kirton; Daniel S Mills
Journal:  Animals (Basel)       Date:  2022-02-26       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.